Jean-Pierre Zellweger

Dr. Jean-Pierre Zellweger


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2020 in La Medicina del Lavoro
Verified
Journal Article
Open access
PDF file
JZJean-Pierre Zellweger
Jean-Pierre Zellweger
Giovanni SotgiuGiovanni Sotgiu
Giovanni Sotgiu
Massimo CorradiMassimo Corradi
Massimo Corradi
Paolo DurandoPaolo Durando
Paolo Durando
Introduction: Despite great efforts, tuberculosis (TB) is still a major public health threat worldwide. For decades, TB control programs have focused almost exclusively on infectious TB active cases. However, it is evident that this strategy alone cannot achieve TB elimination. To achieve this objective a comprehensive strategy directed toward integrated latent tuberculosis infection (LTBI) management is needed. Recently it has been recognized that LTBI is not a stable condition but rather a spectrum of infections (e.g., intermittent, transient or progressive) which may lead to incipient, then subclinical, and finally active TB disease. Aim: Provide an overview of current available LTBI diagnostic test including updates, future developments and perspectives. Results: There is currently no test for the direct identification of live MT infection in humans. The diagnosis of LTBI is indirect and relies on the detection of an immune response against MT antigens, assuming that the immune response has developed after a contact with the biological agent. Tuberculin skin test (TST) and interferon gamma release assays (IGRAs) are the main diagnostic tools for LTBI, however, both present strengths and limitations. The most ancient diagnostic test (TST) can be associated with several technical errors, has limited positive predictive value, is being influenced by BCG vaccination and several conditions can reduce the skin reactivity. Notwithstanding these limitations, prompt identification of TST conversion, should orientate indications for preventive therapy of LTBI. IGRAs have superior specificity, are not affected by M. bovis, BCG vaccination and other environmental mycobacteria. However, they present some logistical and organisational constraints and are more expensive. Currently, the WHO guidelines recommend that either a TST or an IGRA can be used to detect LTBI in high-income and upper middle-income countries with estimated TB incidences less than 100 per 100,000 population. Two skin tests (C-TB and Diaskintest), using only two specific M. tuberculosis antigens (ESAT-6 and CFP-10) instead of the tuberculin solution, have recently been developed but, to date, none of these tests is available on the European market. Conclusion: Early identification and treatment of individuals with LTBI is an important priority for TB control in specific groups at risk within the population: this is of crucial meaning in recently infected cases both at the community level and in some occupational settings. Currently there is no gold standard test for LTBI: an improved understanding of the available tests is needed to develop better tools for diagnosing LTBI and predicting progression to clinical active disease.

26 May 2005 in Respiratory Research
Verified
Journal Article
Open access
PDF file
SDSara H Downs
Sara H Downs
OBOtto Brändli
Otto Brändli
JZJean-Pierre Zellweger
Jean-Pierre Zellweger
CSChristian Schindler
Christian Schindler
NKNino Kuenzli
Nino Kuenzli
TTthe SAPALDIA team
the SAPALDIA team
Background: The aim was to determine if effects from smoking on lung function measured over 11 years differ between men and women.Methods: In a prospective population based cohort study (Swiss Study on Air Pollution and Lung Diseases in Adults) current smokers in 1991 (18 – 60 yrs) were reassessed in 2002 (n = 1792). Multiple linear regression was used to estimate effects from pack-years of cigarettes smoked to 1991 and mean packs of cigarettes smoked per day between 1991 and 2002 on change in lung volume and flows over the 11 years.Results: In both sexes, packs smoked between assessments were related to lung function decline but pack-years smoked before 1991 were not. Mean annual decline in FEV1was -10.4 mL(95%CI -15.3, -5.5) per pack per day between assessments in men and -13.8 mL(95%CI-19.5,-8.1) in women. Decline per pack per day between 1991 and 2002 was lower in women who smoked in 1991 but quit before 2002 compared to persistent smokers (-6.4 vs -11.6 mL, p = 0.05) but this was not seen in men (-14.3 vs -8.8 mL p = 0.49). Smoking related decline was accelerated in men and women with airway obstruction, particularly in women where decline in FEV1was three fold higher in participants with FEV1/FVC<0.70 compared to other women (-39.4 vs -12.2 mL/yr per pack per day, p < 0.002).Conclusion: There are differences in effects from smoking on lung function between men and women. Lung function recovers faster in women quitters than in men. Women current smokers with airway obstruction experience a greater smoking related decline in lung function than men.

3 November 2007 in Swiss Medical Weekly
Verified
Journal Article
Open access
PDF file
CBChristoph Beglinger
Christoph Beglinger
JDJean Dudler
Jean Dudler
CMChristian Mottet
Christian Mottet
LNLaurent Nicod
Laurent Nicod
FSFrank Seibold
Frank Seibold
JZJean-Pierre Zellweger
Jean-Pierre Zellweger

24 March 2009 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
PBPatrick Bodenmann
Patrick Bodenmann
PVPaul Vaucher
Paul Vaucher
HWHans Wolff
Hans Wolff
BFBernard Favrat
Bernard Favrat
FTFanny de Tribolet
Fanny de Tribolet
JZJean-Pierre Zellweger
Jean-Pierre Zellweger
Migration is one of the major causes of tuberculosis in developed countries. Undocumented patients are usually not screened at the border and are not covered by a health insurance increasing their risk of developing the disease unnoticed. Urban health centres could help identify this population at risk. The objective of this study is to assess the prevalence of latent tuberculosis infection (LTBI) and adherence to preventive treatment in a population of undocumented immigrant patients.

1 May 2005 in American Journal of Health Behavior
Verified
Journal Article
Closed access
JZJean-Pierre Zellweger
Jean-Pierre Zellweger
PBPal Laszio Boelcskei
Pal Laszio Boelcskei
LCLaura Carrozzi
Laura Carrozzi
RSRuth Sepper
Ruth Sepper
RSRuth Sweet
Ruth Sweet
AHAmy Z. Hider
Amy Z. Hider
Objective: To evaluate bupropion SR for smoking cessation in physicians and nurses. Methods: This double-blind prospective 26-center, 12-country trial randomized 687 subjects to smoking cessation counselling with bupropion SR or placebo for 7 weeks. The participants were followed for 52 weeks. Results: Bupropion SR was superior to placebo (50% vs 40%, P=0.013) on the 4-week primary outcome variable. Due to a high placebo response in this health care population, statistical differences were not maintained after treatment was discontinued. Conclusions: Bupropion SR is effective and well tolerated in health care professionals. Relapse prevention measures are needed to attain long-term abstinence.

31 December 2009 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
OKOmar Kherad
Omar Kherad
FHFrançois R Herrmann
François R Herrmann
JZJean-Pierre Zellweger
Jean-Pierre Zellweger
TRThierry Rochat
Thierry Rochat
JJJean-Paul Janssens
Jean-Paul Janssens
The incidence of tuberculosis (TB) in developed countries has decreased since the 1990s, reflecting worldwide efforts to identify and treat TB according to WHO recommendations. However TB remains an important public health problem in industrialized countries with a high proportion of cases occurring among subjects originating from high prevalence countries. The aim of this study was to describe clinical and social characteristics of patients with TB and their outcome in a low incidence area with a high immigration rate.